EMD SERONO, INC. for EMD SERONO INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 22, 2012 | $680,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Oct 25, 2012 | $730,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 3522/S. 965: FAMILY ACT OF 2011; ALL PROVISIONS OF THE BILLS
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID NICHOLS | — |
| LYNN TAYLOR | — |
Health Issues HCR
H.R. 6433: FDA USER FEE CORRECTIONS ACT OF 2012; ALL PROVISIONS OF THE BILL IMPLEMENTATION OF PATIENT PROTECTION AND AFFORDABLE CARE ACT REAUTHORIZATION OF PRESCRIPTION DRUG USER FEE ACT
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID NICHOLS | — |
| LYNN TAYLOR | — |
Pharmacy PHA
SUPPLY CHAIN INTEGRITY ISSUES
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID NICHOLS | — |
| LYNN TAYLOR | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| MERCK KGAA | Germany | Germany | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.